1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Gastroparesis Market – By Type

1.3.2        North America Gastroparesis Market – By Drug Class Type

1.3.3        North America Gastroparesis Market – By Distribution Channel

1.3.4        North America Gastroparesis Market – By Country

2.           North America Gastroparesis Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Gastroparesis Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           North America Gastroparesis Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Diabetes Mellitus Prevalence

5.1.2        Rising Geriatric Population

5.2         Market Restraints

5.2.1        Side Effects Associated with Gastroparesis Drugs

5.3         Market Opportunities

5.3.1        Rising Investments and Financial Assistance Related to Research

5.4         Future Trends

5.4.1        Gastric Electrical Stimulation Therapy Research Getting Popular

5.5         Impact Analysis

6.           Gastroparesis Market – North America Analysis

6.1         North America Gastroparesis Market Revenue Forecast and Analysis

7.           North America Gastroparesis Market Analysis – By Type

7.1         Overview

7.2         North America Gastroparesis Market Revenue Share, by Type (2019 and 2027)

7.3         Idiopathic

7.3.1        Overview

7.3.2        Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Diabetic

7.4.1        Overview

7.4.2        Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Post-Surgical

7.5.1        Overview

7.5.2        Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.           North America Gastroparesis Market Analysis – By Drug Class Type

8.1         Overview

8.2         North America Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

8.3         Prokinetic Agents

8.3.1        Overview

8.3.2        Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Botulinum Toxin Injection

8.4.1        Overview

8.4.2        Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Antiemetic Agents

8.5.1        Overview

8.5.2        Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.           North America Gastroparesis Market Analysis – By Distribution Channel

9.1         Overview

9.2         North America Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3         Retail Pharmacies

9.3.1        Overview

9.3.2        Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.        North America Gastroparesis Market – Country Analysis

10.1      Overview

10.1.1     North America: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.1.2     US: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.1       US: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.2       US Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.3       US Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.4       US Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.3     Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1       Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2       Canada Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.3       Canada Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.4       Canada Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

10.1.4     Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1       Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2       Mexico Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4.3       Mexico Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.4.4       Mexico Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on North America Gastroparesis Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        Gastroparesis Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Gastroparesis Market, 2018-2020

12.3      Inorganic Growth Strategies

12.3.1     Overview

12.4      Organic Growth Strategies

12.4.1     Overview

13.        Company Profiles

13.1      Evoke Pharma

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Allergan Plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      NEUROGASTRX, INC.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bausch Health Companies Inc. (Salix Pharmaceuticals)

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Pfizer Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      ANI Pharmaceuticals, Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Ipca Laboratories Ltd

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   CinRx Pharma, LLC (CinDome Pharma)

13.10.1  Business Description

13.10.2  Products and Services

13.10.3  Financial Overview

13.10.4  SWOT Analysis

13.10.5  Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

Table 1.             US Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             US Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             US Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 4.             Canada Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             Canada Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Canada Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 7.             Mexico Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Mexico Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             Mexico Gastroparesis Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 10.          Recent Inorganic Growth Strategies in the Gastroparesis market

Table 11.          Recent Organic Growth Strategies In the Gastroparesis market

Table 12.          Glossary of Terms, North America Gastroparesis Market

Figure 1.           North America Gastroparesis Market Segmentation

Figure 2.           North America Gastroparesis Market Segmentation, By Country

Figure 3.           North America Gastroparesis Market Overview

Figure 4.           Idiopathic Segment Held Largest Share of North America Gastroparesis Market

Figure 5.           US to Show Remarkable Growth During Forecast Period

Figure 6.           North America PEST Analysis

Figure 7.           North America Gastroparesis Market Impact Analysis of Drivers and Restraints

Figure 8.           North America Gastroparesis Market – Revenue Forecast And Analysis – 2019- 2027

Figure 9.           North America Gastroparesis Market Revenue Share, by Type (2019 and 2027)

Figure 10.        North America Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        North America Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        North America Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        North America Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        North America Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

Figure 15.        North America Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        North America Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        North America Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        North America Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 19.        North America Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        North America Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        North America Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        North America: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        North America: Gastroparesis Market, by Country, 2019 & 2027 (%)

Figure 24.        US: Pharmaceutical Drug Delivery market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        Canada: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        Mexico: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 28.        Growth Strategies in the Gastroparesis Market, 2018-2020